Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

September 07, 2021 10:00 ET | Source: COMPASS Pathfinder Ltd.

COMPASS Pathways to participate in Citi, Morgan Stanley and HC Wainwright investor conferences in September

London, UK – Sept. 07, 2021 (GLOBE NEWSWIRE) COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based...
June 28, 2021 07:00 ET | Source: COMPASS Pathfinder Ltd.

COMPASS Pathways completes COMP360 psilocybin therapy administration for 216 patients in large-scale phase IIb psilocybin therapy trial for treatment-resistant depression

London, UK, June 28, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in...
June 23, 2021 07:00 ET | Source: COMPASS Pathfinder Ltd.

COMPASS Pathways becomes Founding Supporter of the British Neuroscience Association’s inaugural Scholars programme

Programme aims to support students from under-represented ethnic groups London, UK – 23 June 2021 COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to...
June 08, 2021 07:00 ET | Source: COMPASS Pathfinder Ltd.

COMPASS Pathways plc to participate in JMP Securities and H.C. Wainwright investor conferences

LONDON, June 08, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,...
June 03, 2021 09:27 ET | Source: COMPASS Pathfinder Ltd.

COMPASS Pathways and Kings College London publish cognition results from COMP360 psilocybin study in healthy volunteers

LONDON, June 03, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS) (“COMPASS”), a mental health care company dedicated to accelerating patient access to evidence-based innovation in...
May 13, 2021 07:00 ET | Source: COMPASS Pathfinder Ltd.

COMPASS Pathways plc announces financial results and business highlights for the first quarter 2021

Highlights: New England Journal of Medicine publishes exploratory study showing signals of positive activity in COMP360 psilocybin compared with escitalopram for major depressive disorder Two...
May 06, 2021 08:00 ET | Source: COMPASS Pathfinder Ltd.

COMPASS Pathways plc to announce first quarter 2021 financial results on 13 May 2021

London, UK, May 06, 2021 (GLOBE NEWSWIRE) -- COMPASS Pathways plc (Nasdaq: CMPS), a mental health care company dedicated to accelerating patient access to evidence-based innovation in mental health,...
January 08, 2021 07:47 ET | Source: Compass Pathways

COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care

COMPASS Pathways establishes Centre of Excellence with Sheppard Pratt to accelerate research and improve patient experience in mental health care London, UK – 8 January 2021 COMPASS Pathways plc...